Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1077 | 1004 | 1077 | 1120 | 1260 | 1667 |
Fund Return | 7.67% | 0.44% | 7.67% | 3.85% | 4.73% | 5.24% |
Place in category | 316 | 203 | 316 | 100 | 68 | 37 |
% in Category | 50 | 36 | 50 | 20 | 15 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Eaton Vance Short Duration Strat I | 6.39B | 6.65 | 4.17 | 3.89 | ||
Eaton Vance Income Fund of Boston I | 3.85B | 7.34 | 3.46 | 4.83 | ||
Eaton Vance Core Plus Bond Fund Cli | 2.12B | 4.33 | -0.90 | 2.80 | ||
Eaton Vance Short Duration Gov I | 2.03B | 4.08 | 1.53 | 1.60 | ||
Eaton Vance Glbl Macr Absolute RetI | 1.44B | 8.69 | 4.99 | 3.77 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
US1868542044 | 32.42B | 12.61 | 10.56 | - | ||
Vanguard High-Yield Corporate Adm | 21.58B | 6.39 | 2.66 | 4.60 | ||
Fidelity Capital & Income | 13.54B | 10.68 | 3.84 | 6.58 | ||
BlackRock High Yield Bond Instl | 12.69B | 8.63 | 3.38 | 5.07 | ||
BlackRock High Yield Bond K | 12.29B | 8.74 | 3.48 | 5.17 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
iShares Broad USD High Yield Corporate Bond | US46435U8532 | 3.78 | 37.35 | +0.15% | |
Medline Borrower LP 5.25% | - | 0.77 | - | - | |
Minerva Merger Subordinated Inc. 6.5% | - | 0.71 | - | - | |
FORTRESS INTERMEDIATE 3 INC TERM LOAN B | - | 0.65 | - | - | |
New Home Company Inc 9.25% | - | 0.62 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | BUY | BUY | Strong Buy |
Summary | Neutral | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review